Novoheart's Acquisition

Novoheart was acquired by Woodrose Ventures on March 13, 2017.

Novoheart develops products and provides services focused on engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardiotoxicity screening, disease modelling a…

Articles about Novoheart's Acquisition: